Fagan Associates, Inc. Tandem Diabetes Care Inc Transaction History

Fagan Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$86.4 - $121.75 $590,976 - $832,770	-6,840 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$95.43 - $116.09 $989,131 - $1.2 Million	-10,365 Reduced 60.24%	6,840 $776,000
Q2 2020 Aug 05, 2020	BUY	$60.05 - $98.92 $1.03 Million - $1.7 Million	17,205 New	17,205 $1.7 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Fagan Associates, Inc. with notifications on news.